Back to results
US 12,577,232 B2Granted
N-heterocycle substituted tryptamine derivatives and methods of using
AssigneeEnveric Biosciences Canada Inc.
InventorsDavid James Press, Glynnis Elizabeth Jensen, Kaveh Matinkhoo, Jessica Bik-Jing Lee, Jillian M. Hagel, Peter J. Facchini
Life of this patent
Estimating the term…
Abstract
Disclosed are novel N-heterocycle-substituted tryptamine derivative compounds and pharmaceutical and recreational drug formulations containing the same. The pharmaceutical formulations may be used to treat brain neurological disorders.
Claims29
A chemical compound having chemical formula (I):
- wherein one of R2, R4, R6, and R7 is an N-heterocycle substituent and one of R2, R4, R6, and R7 is a halogen atom, and wherein each of R2, R4, R6, and R7 which are not an N-heterocycle substituent or a halogen atom are a hydrogen atom, wherein R5 is a halogen atom or a hydrogen atom, wherein R1 is alkyl or hydrogen, and wherein R3a and R3b are each independently a hydrogen atom, an alkyl group, an aryl group, or an alkyl-aryl group, wherein the N-heterocycle substituent is an N-linked heterocyclic ring.
Dependencies are inferred from the claim text.